test

Robert J. Wenzel

@Aisling Capital Management Lp

Latest period2024 - Q3ReportedManaged Assets$261.072MTotal holdings16
Assets growth rate13%Assets growth rate (2-Q avg)-4.4%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Aisling Capital Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 16 positions.

Assets under management

The assets under management (AUM) of Aisling Capital Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 261.072M in assets, with a quarterly growth rate of 13% and a 2-quarter average growth rate of -4.4%. The portfolio is managed by Robert J. Wenzel, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
BBIOBridgebio Pharma Inc. (bbio)
Recent Activity
59.18%
$154.494M
6.068M shares@ $25.47 avg price
VRNAVerona Pharma Plc (vrna)
Recent Activity
12.3%
$32.089M
1.115M shares@ $28.77 avg price
SNDXSyndax Pharmaceuticals, Inc. (sndx)
Recent Activity
7.56%
$19.731M
1.025M shares@ $19.25 avg price
BCAXBicara Therapeutics Inc. (bcax)
Recent Activity
New Position
5.56%
$14.49M
568,919 shares@ $25.48 avg price
BMEABiomea Fusion Inc (bmea)
Recent Activity
3.1%
$8.067M
798,757 shares@ $10.11 avg price
GLUEMonte Rosa Therapeutics Inc (glue)
Recent Activity
2.99%
$7.803M
1.472M shares@ $5.3 avg price
CMPSCompass Pathways Plc (cmps)
Recent Activity
2.33%
$6.076M
964,500 shares@ $6.3 avg price
NUVBNuvation Bio Inc. (nuvb)
Recent Activity
2.23%
$5.819M
2.541M shares@ $2.3 avg price
PSTXPoseida Therapeutics Inc. (pstx)
Recent Activity
1.15%
$2.984M
1.043M shares@ $2.87 avg price
TECXTectonic Therapeutic Inc (tecx)
Recent Activity
0.98%
$2.55M
84,148 shares@ $30.3 avg price